NVDA
NVIDIA Corporation
NVDA's fundamentals are strong and it looks cheap: trading at 21x earnings, about a third of its usual 65x. Analysts expect strong earnings growth.
RDZN
Roadzen, Inc.
There isn't enough reported data to score RDZN yet.
NVDA Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
NVDA's revenue, profitability, cash flow and balance sheet are all currently strong.
RDZN Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Under pressure | |
| Unavailable | |
| Unavailable |
RDZN's revenue is currently strong, but its profitability is under pressure. There isn't enough data to rate its cash flow and balance sheet.
NVDA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 12x | $166 | — |
| Current | 21x | $166 | — |
| Cheap | 44x | $345 | +108% |
| Fair | 65x | $511 | +207% |
| Expensive | 93x | $734 | +342% |
Historical ranges are pointers, not guarantees.
NVDA's PE is in its cheap range at 21x. If earnings grow as analysts expect, today's price would be 12x next year's earnings.
RDZN PE Valuation
RDZN has no meaningful PE right now: it lost money over the past year.
NVDA Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Weakening | |
| Broad | |
| Moderate |
Analysts expect strong earnings and revenue growth for NVDA, but weaker profitability.
RDZN Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| High |
RDZN has the edge over NVDA on the outlook, with more favorable profitability expectations.
NVDA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.77 | +74% |
| Q3 2026 | $7.91 | +125% |
| Q2 2026 | $6.53 | +111% |
| Q1 2026 | $4.90 | +67% |
| Q4 2025 | $4.03 | +59% |
| Q3 2025 | $3.51 | +65% |
| Q2 2025 | $3.10 | +81% |
| Q1 2025 | $2.94 | +147% |
| Q4 2024 | $2.54 | +234% |
NVDA has the edge over RDZN on earnings quality, reporting a profit while its opponent remains loss making.
RDZN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$0.36 | +$0.05 |
| Q1 2026 | -$0.29 | +$0.78 |
| Q4 2025 | -$0.20 | +$1.28 |
| Q3 2025 | -$0.12 | +$1.77 |
| Q2 2025 | -$0.41 | +$2.56 |
RDZN lost $0.36 per share over the past year, a smaller loss than the year before, but its loss has widened in each of the last three quarters.
NVDA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $96.2B | +106% |
| Q2 2026 | $81.6B | +85% |
| Q1 2026 | $68.1B | +73% |
| Q4 2025 | $57B | +62% |
| Q3 2025 | $46.7B | +56% |
| Q2 2025 | $44.1B | +69% |
| Q1 2025 | $39.3B | +78% |
| Q4 2024 | $35.1B | +94% |
NVDA has the edge over RDZN on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 66% | +5.4 points |
| Q2 2026 | 66% | +17 points |
| Q1 2026 | 65% | +3.9 points |
| Q4 2025 | 63% | +0.8 points |
| Q3 2025 | 61% | -1.2 points |
| Q2 2025 | 49% | -16 points |
| Q1 2025 | 61% | -0.5 points |
| Q4 2024 | 62% | +4.9 points |
NVDA has the edge over RDZN on profitability, with a higher operating margin.
RDZN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q1 2026 | $16.1M | +41% |
| Q4 2025 | $14.4M | +19% |
| Q3 2025 | $13.7M | +15% |
| Q2 2025 | $10.9M | +22% |
| Q1 2025 | $11.4M | +14% |
| Q4 2024 | $12.1M | -23% |
| Q3 2024 | $11.9M | -23% |
| Q4 2023 | $15.6M | +372% |
RDZN's revenue has grown year over year for five quarters in a row: $16M last quarter, up 41% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q1 2026 | -36% | -3.3 points |
| Q4 2025 | -16% | +9.8 points |
| Q3 2025 | -24% | +174 points |
| Q2 2025 | -23% | +317 points |
| Q1 2025 | -33% | +317 points |
| Q4 2024 | -26% | +174 points |
| Q3 2024 | -198% | -150 points |
| Q2 2024 | -340% | N/A |
RDZN's operating margin was −36% last quarter, down 3.3 points from the same quarter a year ago.
NVDA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $21.4B | +59% |
| Q2 2026 | $48.6B | +86% |
| Q1 2026 | $34.9B | +124% |
| Q4 2025 | $22.1B | +32% |
| Q3 2025 | $13.5B | -0.3% |
| Q2 2025 | $26.2B | +75% |
| Q1 2025 | $15.6B | +38% |
| Q3 2024 | $13.5B | +113% |
NVDA has the stronger cash trend. Its trailing FCF is up 290% versus its history, compared with RDZN at down 67%.
RDZN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$5.9M | -$3M |
| Q4 2025 | -$7.5M | -$4.3M |
| Q3 2025 | -$6.1M | -$493K |
| Q2 2025 | -$2.9M | +$2.7M |
| Q1 2025 | -$3.7M | -$2.8M |
| Q4 2024 | -$3.2M | -1328% |
| Q4 2023 | $259.1K | +$2.2M |
| Q4 2022 | -$1.9M | -$1.9M |
RDZN has burned cash in almost every quarter: −$22M over the past year, against −$18M the year before.
NVDA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.1x | Very low |
| Q2 2026 | -0.0x | Net Cash |
| Q1 2026 | -0.0x | Net Cash |
| Q4 2025 | -0.0x | Net Cash |
| Q3 2025 | -0.0x | Net Cash |
| Q2 2025 | -0.1x | Net Cash |
| Q1 2025 | -0.0x | Very low |
| Q4 2024 | -0.0x | Net Cash |
NVDA's net debt is less than a year of its operating earnings (EBITDA), after holding more cash than debt a year ago.
RDZN Net Leverage
RDZN's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
NVDA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.4 | Neutral |
| Stochastic | 18.1 | Oversold |
NVDA's weekly RSI is 33 (neutral) and its Stochastic is 18 (oversold).
RDZN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 41.9 | Neutral |
| Stochastic | 21.3 | Neutral |
RDZN's weekly RSI is 42 (neutral) and its Stochastic is 21 (neutral).
NVDA PE vs Technology Sector
| Metric | NVDA | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 28x | 25% below |
| PE % | 0 | 35 | 35 pts below |
NVDA is trading at 21x earnings, a 25% discount to the Technology sector's median of 28x.
RDZN PE vs Technology Sector
RDZN has no meaningful PE right now: it lost money over the past year.
NVDA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $208.9 | 20% below |
| 20 week MA | $212.0 | 22% below |
| 50 week MA | $199.9 | 17% below |
| 100 week MA | $175.1 | 5.1% below |
| 200 week MA | $123.6 | 34% above |
NVDA has stronger trend alignment. NVDA is above 1 of 5 weekly averages versus RDZN above 0 of 4.
RDZN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.16 | 10% below |
| 20 week MA | $1.24 | 16% below |
| 50 week MA | $1.46 | 29% below |
| 100 week MA | $1.35 | 23% below |
RDZN is in a downtrend: it's below all four of its weekly moving averages, and 23% below its 100-week average.
NVDA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $5.92 | $13.0 | +119% |
| 2021 | $13.0 | $29.6 | +128% |
| 2022 | $29.6 | $15.2 | -49% |
| 2023 | $15.2 | $49.5 | +226% |
| 2024 | $49.5 | $137.0 | +177% |
| 2025 | $137.0 | $190.5 | +39% |
| 2026 YTD | $190.5 | $166.2 | -13% |
NVDA has the edge over RDZN on returns for 2026, with the stronger performance.
RDZN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2023 | $10.1 | $5.09 | -50% |
| 2024 | $5.09 | $2.14 | -58% |
| 2025 | $2.14 | $2.05 | -4.2% |
| 2026 YTD | $2.05 | $1.04 | -49% |
RDZN has finished every year since 2023 lower, and it's down 49% so far in 2026.